CDT Equity Inc.
CDT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.
Other share classesCDTTW
Q1 2024 vs. Q4 2023
How the institutions holding CDT Equity Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 11 | 18 | +7 |
| Shares | 1.38M | 1.61M | +236.3K (+17.2%) |
| Value | $6.26M | $5.91M | −$348.8K (−5.6%) |
New holders (8)
Institutions that held CDT Equity Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 68,550 | $251.6K | 0.00% |
| Marshall Wace, LLP | 61,954 | $227.4K | 0.00% |
| Qube Research & Technologies Ltd | 40,985 | $150.4K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 19,272 | $70.7K | 0.01% |
| State Street Corp | 15,300 | $56.2K | 0.00% |
| Morgan Stanley | 11,787 | $43.3K | 0.00% |
| UBS Group AG | 41 | $151 | 0.00% |
| Macquarie Group Ltd | 195 | $1 | 0.00% |
Sold out (1)
Institutions that held CDT Equity Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 16,574 | $75.4K |